LENZ Therapeutics, Inc. (LENZ)
NASDAQ: LENZ · Real-Time Price · USD
29.96
+0.19 (0.64%)
At close: Aug 1, 2025, 4:00 PM
29.66
-0.30 (-1.00%)
After-hours: Aug 1, 2025, 6:32 PM EDT

LENZ Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
37.6120.1635.1444.4418.31
Short-Term Investments
171.91188.8730.65--
Cash & Short-Term Investments
209.52209.0365.7944.4418.31
Cash Growth
6.84%217.70%48.05%142.75%-
Prepaid Expenses
2.672.771.452.20.02
Restricted Cash
0.110.11---
Total Current Assets
213.6211.9267.2446.6418.32
Property, Plant & Equipment
2.131.990.370.280.01
Long-Term Deferred Charges
--2.74--
Other Long-Term Assets
1.61.40.020.030
Total Assets
217.33215.370.3846.9518.34
Accounts Payable
2.854.265.714.760.46
Accrued Expenses
7.065.5812.674.290.79
Current Portion of Leases
0.480.570.140.1-
Current Income Taxes Payable
---0.35-
Total Current Liabilities
10.410.4118.519.51.25
Long-Term Leases
0.570.810.190.15-
Other Long-Term Liabilities
--0.120.07-
Total Liabilities
10.9711.2218.839.711.25
Common Stock
005.915.915.9
Additional Paid-In Capital
380.87348.92.521.10.25
Retained Earnings
-174.55-145.01-95.25-25.28-14.47
Comprehensive Income & Other
0.040.20.01--
Total Common Equity
206.37204.08-86.81-18.27-8.31
Shareholders' Equity
206.37204.0851.5537.2417.08
Total Liabilities & Equity
217.33215.370.3846.9518.34
Total Debt
1.051.380.330.25-
Net Cash (Debt)
208.47207.6565.4744.1918.31
Net Cash Growth
7.23%217.19%48.14%141.39%-
Net Cash Per Share
7.559.7633.424.671.96
Filing Date Shares Outstanding
28.5227.5425.539.639.36
Total Common Shares Outstanding
28.527.529.749.639.36
Working Capital
203.2201.5148.7337.1417.07
Book Value Per Share
7.247.42-8.91-1.90-0.89
Tangible Book Value
206.37204.08-86.81-18.27-8.31
Tangible Book Value Per Share
7.247.42-8.91-1.90-0.89
Machinery
-0.480.070.050.02
Leasehold Improvements
-0.10.01--
Updated Jul 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q